Abstract
In the dynamic landscape of cancer treatment, discovery-based research in T cell biology has proven transformative, ushering in revolutionary immunotherapies. This paper navigates the impact of fundamental research on cancer therapy, tracing its evolution from 19th-century trailblazers Wilhelm Busch and Friedrich Fehleisen to recent breakthroughs by James P. Allison. By understanding T cells, the immune system's superheroes, we can illuminate the pivotal role of selectively targeting and eliminating cancer cells with unprecedented precision. Advances such as checkpoint blockade antibodies have freed tumor-infiltrating T cells from inhibition, allowing them to kill tumor cells effectively. This was a revolutionary breakthrough. Historical insights, such as the discovery of immunocompetent recirculating lymphocytes and the function of the thymus, laid the groundwork for these advances. This ongoing dialogue on resource allocation recognizes foundational research as the cornerstone for innovative therapies, ensuring a sustainable pipeline of discoveries that shape the future of T cell cancer treatment.
Publisher
University of Alberta Libraries
Reference22 articles.
1. Allison, J. P. (2018, December). Immune Checkpoint Blockade in Cancer Therapy . Nobel Lecture. San Francisco; California .
2. Boorman, G. A., & Everitt, J. I. (2006). Neoplastic disease. The Laboratory Rat, 479–511. https://doi.org/10.1016/b978-012074903-4/50017-0
3. Cleveland Clinic medical professional (Ed.). (2023, January 17). T cells: Types and function. Cleveland Clinic. https://my.clevelandclinic.org/health/body/24630-t-cells
4. Ferretti, J., & Köhler, W. (2016). History of Streptococcal Research. In Streptococcus pyogenes: Basic Biology to Clinical Manifestations. University of Oklahoma Health Sciences Center, Oklahoma City (OK). PMID: 26866232.
5. Gowans, J. L., McGREGOR, D. D., COWEN, D. M., & FORD, C. E. (1962). Initiation of immune responses by small lymphocytes. Nature, 196(4855), 651–655. https://doi.org/10.1038/196651a0